Capricor Therapeutics CCO Michael Maurer Granted 80,000 Stock Options

This Form 4 filing reports that Michael T. Maurer, Chief Commercial Officer of Capricor Therapeutics, Inc., was granted 80,000 stock options on May 26, 2026. The options have an exercise price of $29.36 per share and expire on May 26, 2036. The options vest over four years, with 25% vesting on the first anniversary of the grant date and the remainder vesting monthly over the following 36 months. The filing notes that the options are subject to early exercise, allowing Maurer to purchase shares before they vest, though any unvested shares would be subject to repurchase by the company if his service terminates before vesting occurs. Following this transaction, Maurer holds 80,000 stock options in total. The filing was signed by Linda Marban as Attorney-in-Fact on May 28, 2026.